Menu

Important Document

Important Document

Sr. No. Title Details
1 Timeline extended till 21.07.2025 - Invitation of applications for eligible products under the Production Linked Incentive Scheme for Bulk Drugs
2 Modification in the operational guidelines of sub-scheme Capacity Building and Skill Development for Medical Devices under the scheme Strengthening of Medical Device Industry-regarding.
3 Invitation of applications for the eligible products under Production Linked Incentive Scheme for Bulk Drugs-reg.
4 Department of Pharmaceuticals invites applications to fill up the post of Chief Executive Officer (CEO) in Pharmaceutical and Medical Devices Bureau of India (PMBI)
5 Extension of last date for receipt of applications- Inviting applications from the retired employees of Central Govt. Departments/ Public Sector Undertaking for rendering their services as Consultant
6 Inviting applications from the retired employees of Central Govt. Departments/ Public Sector Undertaking for rendering their services as Consultant in Department of Pharmaceuticals, Ministry of Chemical and Fertilizers - regarding.
7 Frequently Asked Questions (FAQs) regarding the Promotion of Research and Innovation in Pharma MedTech (PRIP) Scheme.
8 Department of Pharmaceuticals invites Expression of Interest (EoI) from interested entities under the PRIP scheme
9 Applications for the posts of Director of NIPER-Kolkata
10 Apex Committee Order dated 23.12.2024 in case of M/s AbbVie Healthcare India Pvt. Ltd. under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024
11 Vacancy circular for engagement of Consultants (02 Nos.) on contractual basis- reg.
12 Invitation of applications under the Scheme Assistance to Pharmaceutical Industry for Common Facilities (API-CF) w.e.f. 11.12.2024 to 13.01.2025.
13 Operational Guidelines for the Scheme 'Strengthening of Medical Device Industry'
14 Selection for the post of Managing Director, Karnataka Antibiotics & Pharmaceuticals Limited (KAPL), a schedule 'C' CPSE- Advertisement reg.
15 Press Releases :PM to inaugurate five projects under the PLI scheme for medical devices and bulk drugs
16 Modification in the guidelines of Production Linked Incentive (PLI) Scheme Bulk Drugs
17 Notification of the modification in the clauses under subscheme Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS) - reg.
18 14 सितम्बर, 2024 को हिन्दी दिवस के उपलक्ष्य में सचिव (औषध) का संदेश
19 Message from Hon'ble Minister (C&F) on Swachhta Pakhwada During 1-15 September 2024
20 Message from Hon'ble MoS (C&F) on Swachhta Pakhwada During 1-15 September 2024
21 Standing Order - Circular No. 2 of 2024 under UCPMP-2024
22 Additional charge of the post of Chairman, National Pharmaceuticals Pricing Authority (NPPA) assigned to Shri Arunish Chawla, Secretary, Department of Pharmaceuticals
23 Corrigendum (date & technical) Regarding Tender for Selection of Consulting Firm for strategy development and implementation of the Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector Scheme.
24 Invitation for a pre-bid meeting regarding Tender for Selection of Consulting Firm for strategy development and implementation of the Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector Scheme - Reg.
25 Study report on Bridging Academia-Industry Gap to achieve Self-reliance
    26 Study Report on Impact of the Drug Price Control Order (DPCO) 2013 on the price of Cardiac stents Knee implants and six medical devices on industry and consumers in terms of availability and affordability
      27 Standing Order- Circular No. 1 of 2024 under UCPMP-2024
      28 Recruitment of Young Professionals on contract basis in Department of Pharmaceuticals- reg.
      29 Advertisement for engagement of Young Professionals (2), Junior Consultant (1), Senior Consultant (1) for Project Management Unit of PRIP Scheme.
      30 Term of Reference for Hiring of Young Professionals (2), Junior Consultant (1), Senior Consultant (1) for Project Management Unit of PRIP Scheme
      31 Recruitment of Young Professionals on contract basis in Department of Pharmaceuticals- reg.
      32 Revised Guidelines for the Scheme - Strengthening of Pharmaceuticals Industry (SPI), Dated 14th March 2024.
      33 Study report on An analysis on leveraging the patent cliff, with drug sales worth USD 251 billion going off-patent and to analyses the different drug pricing methodologies particularly w.r.t. these patented drugs going off-patent
        34 Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 - reg
        35 Public Notice dated 12.03.2024: Inviting details of local manufacturers of Medical Devices
        36 Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country (PLI BD)- reg
        37 Modifications in the guidelines of Production Linked Incentive scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) relating to revision of Scheduled Commercial Operation Date (SCOD) and invocation of bank guarantee - reg
        38 Constitution of a Committee for Reforms in the Pricing Framework for Drugs and Medical Devices.
        39 Modifications/ Clarifications in the Operational Guidelines for the Production Linked Incentive (PU) Scheme for Pharmaceuticals - Dated 11th March, 2024
        40 Guidelines for the Scheme (Strengthening of Pharmaceuticals Industry (SPI)) - Revamping of the PTUAS sub-scheme and Notification of the modification in the guidelines - reg.
        41 Public Notice dated 08.03.2024: Inviting details of local manufacturers of specific Drugs/Medicines/Pharmaceutical Formulations
        42 Invitation of applications under the Scheme Assistance to Medical Device Clusters for Common Facilities (AMD-CF)-regarding.
        43 Result of Consultant's interview
        44 Examination Call letter for Young Professionals
        45 Extension of Timeline for Invitation of Applications from eligible category B Applicants under the revised guidelines of PLI - Medical Devices till 29.02.2024- reg
        46 Notice for Invitation of applications under the Scheme 'Assistance to Medical Device Clusters for Common Facilities' (AMD-CF)-regarding.
        47 Study on Upgrading NIPERs to meet evolving needs of Pharmaceutical business and NIPERs in top 50 in world ranking
          48 Eligible/ineligible candidates for the post of Consultant.
          49 Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of Medical Devices (PLI - MD) to invite applications for the eligible products as per Annexure-1A for Category-B applicant dated 19.12.2023
          50 Invitation of applications from eligible Category-B applicants for 30 days under the corrigendum/addendum dated 19/12/2023 read with the revised guidelines of PLI scheme for promoting domestic manufacturing of the Medical Devices dated 25.02.2023- reg.

          Pages